Prior to cofounding qPharmetra, Dr. Dykstra was Sr. Vice President, Strategic Consulting Services with Pharsight where he led an international consultancy providing strategic pharmacometric services to Pharmaceutical and Biotechnology companies. During his nearly 10 years with Pharsight, he led 40+ pharmacometric projects with over 20 client organizations. He also worked with clients to help them develop their own internal Modeling and Simulation capabilities. He has deep experience in using, and educating clients how to use sophisticated, integrated pharmacometric methods to address complex drug development questions. These methods include PK/PD Modeling, Clinical Trial Simulation and Decision Analysis. Before joining Pharsight, Dr. Dykstra was Associate Director of Clinical Pharmacology with Genetics Institute (Wyeth), where he also worked as a Biostatistician in the Biostatistics and Clinical Information Systems Group, designing and analyzing Phase I-III clinical trials. He started his post-doctoral scientific career as a Staff Fellow at the National Institutes of Health, where he studied tissue transport of small molecules. He holds an MS and PhD in Chemical Engineering from the University of Michigan, undergraduate degrees in Chemical Engineering and German from the University of Colorado, and additional training in Biostatistics from Boston University. He is a Fellow of the American College of Clinical Pharmacology.